Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2011 Jun;20(6):1146-55.
doi: 10.1158/1055-9965.EPI-10-0996. Epub 2011 Apr 14.

Decision tree-based modeling of androgen pathway genes and prostate cancer risk

Affiliations
Comparative Study

Decision tree-based modeling of androgen pathway genes and prostate cancer risk

Jill S Barnholtz-Sloan et al. Cancer Epidemiol Biomarkers Prev. 2011 Jun.

Abstract

Background: Inherited variability in genes that influence androgen metabolism has been associated with risk of prostate cancer. The objective of this analysis was to evaluate interactions for prostate cancer risk by using classification and regression tree (CART) models (i.e., decision trees), and to evaluate whether these interactive effects add information about prostate cancer risk prediction beyond that of "traditional" risk factors.

Methods: We compared CART models with traditional logistic regression (LR) models for associations of factors with prostate cancer risk using 1,084 prostate cancer cases and 941 controls. All analyses were stratified by race. We used unconditional LR to complement and compare with the race-stratified CART results using the area under curve (AUC) for the receiver operating characteristic curves.

Results: The CART modeling of prostate cancer risk showed different interaction profiles by race. For European Americans, interactions among CYP3A43 genotype, history of benign prostate hypertrophy, family history of prostate cancer, and age at consent revealed a distinct hierarchy of gene-environment and gene-gene interactions, whereas for African Americans, interactions among family history of prostate cancer, individual proportion of European ancestry, number of GGC androgen receptor repeats, and CYP3A4/CYP3A5 haplotype revealed distinct interaction effects from those found in European Americans. For European Americans, the CART model had the highest AUC whereas for African Americans, the LR model with the CART discovered factors had the largest AUC.

Conclusion and impact: These results provide new insight into underlying prostate cancer biology for European Americans and African Americans.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Overview of Androgen Metabolism Pathway Genes Considered, Including Candidate Genes and Genetic Variants Studied.
Figure 2
Figure 2
Pruned Classification Tree for Androgen pathway in European Americans. The numbers within each node indicate the number of controls / the number of prostate cancer cases.
Figure 3
Figure 3
Pruned Classification Tree for Androgen pathway in African Americans. The numbers within each node indicate the number of controls / the number of prostate cancer cases.
Figure 4
Figure 4
ROC analysis for CART vs. Logistic regression stratified by race. CART -pruned CART model; CARTBASE - CART model only with the adjustment facors; LRCART -logistic regression model including all main effects and interaction terms as found by CART; LRFULL -fully saturated backward selection logistic regression model with interaction terms; LRBASE -logistic regression model only with the adjustment facors.

Similar articles

Cited by

References

    1. Edwards BK, Ward E, Kohler BA, Eheman C, Zauber AG, Anderson RN, et al. Annual report to the nation on the status of cancer, 1975-2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates. Cancer. 2010;116:544–73. - PMC - PubMed
    1. ACS. Cancer Facts and Figures 2010. American Cancer Society, Inc; 2010.
    1. Zeigler-Johnson C, Friebel T, Walker AH, Wang Y, Spangler E, Panossian S, et al. CYP3A4, CYP3A5, and CYP3A43 genotypes and haplotypes in the etiology and severity of prostate cancer. Cancer Res. 2004;64:8461–7. - PubMed
    1. Rebbeck TR, Jaffe JM, Walker AH, Wein AJ, Malkowicz SB. Modification of clinical presentation of prostate tumors by a novel genetic variant in CYP3A4. J Natl Cancer Inst. 1998;90:1225–9. - PubMed
    1. Plummer SJ, Conti DV, Paris PL, Curran AP, Casey G, Witte JS. CYP3A4 and CYP3A5 genotypes, haplotypes, and risk of prostate cancer. Cancer Epidemiol Biomarkers Prev. 2003;12:928–32. - PubMed

Publication types

MeSH terms